1. Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP for treatment of NSCLC and CRC. (December 2016) Authors: Higgins, C.A.; Majkut, J.; Humphreys, L.; Fox, J.; Espona-Fiedler, M.; Malik, A.; Nemeth, Z.; Blurton, P.; Boffey, R.J.; Perrior, T.R.; Haigh, D.; Harrison, T.; Longley, D.B. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗